Tenderwize
Retour à la recherche

Open-house rebate agreement for epinephrine prefilled syringe/prefilled pen

AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen·Erfurt, Germany·Deadline Sep 30, 2026 · 33 days left·Open·Supplies·Framework
Inscrivez-vous pour sauvegarderOpen documents
Titre original de l'avis

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Epinephrin (ATC-Code nach WHO: C01CA24) in der Darr. Fertigspritze/Fertigpen

46/100

Score d'opportunité

Needs reviewMedium complexity
SuppliesFrameworkOpen
Pourquoi ce score ?

Opportunité

46 / 100

Complexité

58 / 100

Facteurs de risque

Participation documents must be submitted via the DTVP communication function, but the notice says some portal instruct...

Only pharmaceutical companies within the meaning of § 4(18) AMG may participate for the offered medicinal products, and...

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Aperçu

Moderate opportunity

Faits clés

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Sep 2026
  • Non-exclusive rebate agreements for epinephrine medicinal products in prefilled syringe/prefilled pen form, excluding 500 micrograms.
  • Open-House participation model with contracts available to all interested eligible pharmaceutical companies during the participation period.
Afficher le résumé complet

This is an Open-House supply arrangement for non-exclusive pharmaceutical rebate agreements under §130a(8) SGB V for epinephrine (ATC C01CA24) in prefilled syringe/prefilled pen form, excluding 500 micrograms. The lead buyer is AOK PLUS. Participation is open to all eligible pharmaceutical companies during the participation period, with no individual negotiations and no supply exclusivity. Submission is electronic via DTVP communication functions, but the notice says some portal instructions are technically misleading and the participation documents must be obtained from the project room. No contract value is stated.

Risques

Participation documents must be submitted via the DTVP communication function, but the notice says some portal instruct...

Only pharmaceutical companies within the meaning of § 4(18) AMG may participate for the offered medicinal products, and...

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Technical

  • Applicant must be a pharmaceutical company within the meaning of § 4(18) AMG for the offered medicinal products.
  • The company must accept the participation requirements and the rebate agreement terms.

Administrative

  • An application for access to the project room is required before downloading the participation documents.

Acheteur

Localisation

Erfurt, DEU

Profil acheteur

Ouvrir le profil

Identifiant

DE256878834

Activité

Health

Lots (1)

LOT-0001

Open-house rebate agreement for epinephrine prefilled syringe/prefilled pen

Single lot covering non-exclusive rebate agreements for medicinal products with epinephrine (ATC C01CA24) in prefilled syringe/prefilled pen presentation, excluding 500 micrograms. The arrangement is an Open-House model with no exclusivity and no individual negotiations. Place of performance is Dresden, Germany, with performance geography stated as Germany, Saxony and Thuringia in the notice text.

SuppliesFrameworkEU fundedElectronic submission

Localisation

Dresden, Germany

Durée

Sep 2025 - Sep 2026

Catégorie

Pharmaceutical products

Date limite

Deadline Sep 30, 2026

Détails de la procédure

Date de publication
31 Jul 2025
Langues
German

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
504736-2025

Documents (1)

Document de consultation 1

Appels d'offres similaires

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 27 - Follitropin delta

Aug 30